• Login
    View Item 
    •   UMB Digital Archive
    • UMB Open Access Articles
    • UMB Open Access Articles
    • View Item
    •   UMB Digital Archive
    • UMB Open Access Articles
    • UMB Open Access Articles
    • View Item
    JavaScript is disabled for your browser. Some features of this site may not work without it.

    Browse

    All of UMB Digital ArchiveCommunitiesPublication DateAuthorsTitlesSubjectsThis CollectionPublication DateAuthorsTitlesSubjects

    My Account

    LoginRegister

    Statistics

    Display statistics

    Strains used in whole organism Plasmodium falciparum vaccine trials differ in genome structure, sequence, and immunogenic potential

    • CSV
    • RefMan
    • EndNote
    • BibTex
    • RefWorks
    Author
    Moser, K.A.
    Dwivedi, A.
    Stucke, E.M.
    Crabtree, J.
    Dara, A.
    Shah, Z.
    Adams, M.
    Munro, J.B.
    Ouattara, A.
    Sparklin, B.C.
    Dunning, Hotopp, J.C.
    Lyke, K.E.
    Sadzewicz, L.
    Tallon, L.J.
    Nyunt, M.M.
    Laufer, M.K.
    Travassos, M.A.
    Takala-Harrison, S.
    Fraser, C.M.
    Plowe, C.V.
    Silva, J.C.
    Drábek, E.F.
    Show allShow less

    Date
    2020
    Journal
    Genome Medicine
    Publisher
    BioMed Central Ltd.
    Type
    Article
    
    Metadata
    Show full item record
    See at
    https://doi.org/10.1186/s13073-019-0708-9
    Abstract
    Background: Plasmodium falciparum (Pf) whole-organism sporozoite vaccines have been shown to provide significant protection against controlled human malaria infection (CHMI) in clinical trials. Initial CHMI studies showed significantly higher durable protection against homologous than heterologous strains, suggesting the presence of strain-specific vaccine-induced protection. However, interpretation of these results and understanding of their relevance to vaccine efficacy have been hampered by the lack of knowledge on genetic differences between vaccine and CHMI strains, and how these strains are related to parasites in malaria endemic regions. Methods: Whole genome sequencing using long-read (Pacific Biosciences) and short-read (Illumina) sequencing platforms was conducted to generate de novo genome assemblies for the vaccine strain, NF54, and for strains used in heterologous CHMI (7G8 from Brazil, NF166.C8 from Guinea, and NF135.C10 from Cambodia). The assemblies were used to characterize sequences in each strain relative to the reference 3D7 (a clone of NF54) genome. Strains were compared to each other and to a collection of clinical isolates (sequenced as part of this study or from public repositories) from South America, sub-Saharan Africa, and Southeast Asia. Results: While few variants were detected between 3D7 and NF54, we identified tens of thousands of variants between NF54 and the three heterologous strains. These variants include SNPs, indels, and small structural variants that fall in regulatory and immunologically important regions, including transcription factors (such as PfAP2-L and PfAP2-G) and pre-erythrocytic antigens that may be key for sporozoite vaccine-induced protection. Additionally, these variants directly contributed to diversity in immunologically important regions of the genomes as detected through in silico CD8+ T cell epitope predictions. Of all heterologous strains, NF135.C10 had the highest number of unique predicted epitope sequences when compared to NF54. Comparison to global clinical isolates revealed that these four strains are representative of their geographic origin despite long-term culture adaptation; of note, NF135.C10 is from an admixed population, and not part of recently formed subpopulations resistant to artemisinin-based therapies present in the Greater Mekong Sub-region. Conclusions: These results will assist in the interpretation of vaccine efficacy of whole-organism vaccines against homologous and heterologous CHMI. Copyright 2020 The Author(s).
    Sponsors
    National Institutes of Health (NIH) awards U19 AI110820, R01 AI141900, R01 AI125579; National Human Genome Research Institute, NHGRI: 1ZIAHG200398; Howard Hughes Medical Institute, HHMI; Small Business Innovation Research, SBIR; Conselho Nacional de Desenvolvimento Científico e Tecnológico, CNPq; National Institute of Allergy and Infectious Diseases, NIAID: 2R44AI058375, U19 AI089683, 5R44AI055229-09A1; Armed Forces Health Surveillance Branch, AFHSB: U19 AI089681, WR1576, WR2017
    Keyword
    Genome assembly
    Malaria
    P. falciparum
    PfSPZ vaccine
    Whole-sporozoite vaccine
    Identifier to cite or link to this item
    https://www.scopus.com/inward/record.uri?eid=2-s2.0-85077677898&doi=10.1186%2fs13073-019-0708-9&partnerID=40&md5=8046505b99a44f880d22a0915fc977cb; http://hdl.handle.net/10713/11678
    ae974a485f413a2113503eed53cd6c53
    10.1186/s13073-019-0708-9
    Scopus Count
    Collections
    UMB Open Access Articles

    entitlement

     
    DSpace software (copyright © 2002 - 2022)  DuraSpace
    Quick Guide | Policies | Contact Us | UMB Health Sciences & Human Services Library
    Open Repository is a service operated by 
    Atmire NV
     

    Export search results

    The export option will allow you to export the current search results of the entered query to a file. Different formats are available for download. To export the items, click on the button corresponding with the preferred download format.

    By default, clicking on the export buttons will result in a download of the allowed maximum amount of items.

    To select a subset of the search results, click "Selective Export" button and make a selection of the items you want to export. The amount of items that can be exported at once is similarly restricted as the full export.

    After making a selection, click one of the export format buttons. The amount of items that will be exported is indicated in the bubble next to export format.